These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15859179)

  • 1. Long-term hospital treatment for patients with chronic obstructive pulmonary disease.
    Lampela P; Säynäjäkangas O; Keistinen T
    Cent Eur J Public Health; 2005 Mar; 13(1):35-9. PubMed ID: 15859179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality after first hospitalization for chronic obstructive pulmonary disease: changes in 1980-1998.
    Säynäjäkangas O; Lampela P; Koiranen M; Keistinen T
    Cent Eur J Public Health; 2004 Mar; 12(1):19-20. PubMed ID: 15068201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the treatment of acute COPD exacerbations in Finland shifting to general practitioners?
    Lampela P; Säynäjäkangas O; Keistinen T
    Scand J Prim Health Care; 2006 Sep; 24(3):140-4. PubMed ID: 16923622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COPD-induced hospitalization burden from first admission to death.
    Kinnunen T; Säynäjäkangas O; Keistinen T
    Respir Med; 2007 Feb; 101(2):294-9. PubMed ID: 16774818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends.
    Geelhoed EA; Brameld KJ; Holman CD; Thompson PJ
    Intern Med J; 2007 Feb; 37(2):87-94. PubMed ID: 17229250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does place of treatment affect prognosis for chronic obstructive pulmonary disease (COPD)?
    Lampela P; Säynäjäkangas O; Jokelainen J; Keistinen T
    Eur J Gen Pract; 2008; 14(3-4):123-8. PubMed ID: 22548298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report.
    Pietinalho A; Kinnula VL; Sovijärvi AR; Vilkman S; Säynäjäkangas O; Liippo K; Kontula E; Laitinen LA
    Respir Med; 2007 Jul; 101(7):1419-25. PubMed ID: 17353122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life.
    Goodridge D; Lawson J; Duggleby W; Marciniuk D; Rennie D; Stang M
    Respir Med; 2008 Jun; 102(6):885-91. PubMed ID: 18313278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High hospital burden in overlap syndrome of asthma and COPD.
    Andersén H; Lampela P; Nevanlinna A; Säynäjäkangas O; Keistinen T
    Clin Respir J; 2013 Oct; 7(4):342-6. PubMed ID: 23362945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization for pneumonia in the Finnish working-age population.
    Säynäjäkangas P; Keistinen T; Honkanen PO; Kivelä SL
    Cent Eur J Public Health; 1997 Mar; 5(1):27-9. PubMed ID: 9151002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal variation in hospital admissions for chronic obstructive pulmonary disease in Finland.
    Vilkman S; Keistinen T; Tuuponen T; Kivelä SL
    Arctic Med Res; 1996 Oct; 55(4):182-6. PubMed ID: 9115544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of chronic obstructive pulmonary disease].
    Vondra V
    Vnitr Lek; 2004 Sep; 50(9):654-8. PubMed ID: 15580895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Length of stay and interval to readmission in emergency hospital treatment of COPD.
    Säynäjäkangas O; Kinnunen T; Tuuponen T; Keistinen T
    Age Ageing; 2004 Nov; 33(6):567-70. PubMed ID: 15347536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
    Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
    Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific.
    Tan WC; Seale P; Ip M; Shim YS; Chiang CH; Ng TP; Abisheganadan J; Charoenratanakul S; DeGuia T; Mahayiddin A; Mangunnegoro H; Xu YJ; Zhong NS
    Respirology; 2009 Jan; 14(1):90-7. PubMed ID: 19144054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in ambulatory visits for chronic obstructive pulmonary disease, based on the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey from 1995 to 2004.
    Suh DC; Lau H; Pokras SM; Choi IS; Valiyeva E
    Respir Care; 2008 Nov; 53(11):1461-9. PubMed ID: 18957148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD).
    Hallin R; Gudmundsson G; Suppli Ulrik C; Nieminen MM; Gislason T; Lindberg E; Brøndum E; Aine T; Bakke P; Janson C
    Respir Med; 2007 Sep; 101(9):1954-60. PubMed ID: 17532198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital use for COPD patients during the last few years of their life.
    Andersson FL; Svensson K; Gerhardsson de Verdier M
    Respir Med; 2006 Aug; 100(8):1436-41. PubMed ID: 16343887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.